Vesalius Longevity Labs Appoints Longevity Entrepreneur Dr. Peter Diamandis to Its Board of Directors

Resumen detallado
Vancouver, British Columbia, November 19th, 2026, FinanceWireXPRIZE founder and globally recognized key opinion leader and entrepreneur joins a...
XPRIZE founder and globally recognized key opinion leader and entrepreneur joins a Board led by Chairman Harvey Spevak, alongside David Adelman, Kevin Mayer, Lee Applbaum, Dr. Kevin Serre, Robert McCue & James McRoberts
Vancouver, British Columbia–(November 19, 2026) – Vesalius Longevity Labs Inc. (CSE:VLAB) (“Vesalius” or the “Company“), a leading global peptide and longevity company, is pleased to announce the appointment of Dr. Peter Diamandis to its Board of Directors (the “Board“), effective November 19, 2026.
Dr. Diamandis is a highly recognized entrepreneur and thought leader in longevity, exponential technology and health innovation. He is the Founder and Executive Chairman of the XPRIZE Foundation; the Executive Founder of Singularity University; Co-founder and Chairman of Fountain Life, an integrated longevity and preventative health platform; and Co-founder of BOLD Capital Partners, a venture fund investing in exponential technologies. Over his career, Dr. Diamandis has founded more than 25 companies across health-tech, space, venture capital and education.
Dr. Diamandis holds degrees in molecular genetics and aerospace engineering from the Massachusetts Institute of Technology and an M.D. from Harvard Medical School. He is a New York Times bestselling author whose books include Abundance: The Future Is Better Than You Think, BOLD: How to Go Big, Create Wealth & Impact the World, The Future Is Faster Than You Think and the #1 bestseller LIFE FORCE, co-authored with Tony Robbins. Fortune has named him one of the “World’s 50 Greatest Leaders.”
As a Director, Dr. Diamandis will support Vesalius’s strategy across its peptide and longevity platform, scientific and clinical positioning, and strategic partnerships as the Company scales its provider network and brand globally.
“We are entering an era in which healthy human lifespan can be meaningfully extended, and peptides are one of the most promising and accessible resources we have to get there,” said Dr.
With the…
Inicio del artículo, extracto de Markets Insider (Business Insider). Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (markets.businessinsider.com)





